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In addition to sunlight and dietary sources, several genes in the metabolic pathway of vitamin D affect 38 
serum 25-hydroxyvitamin D (25OHD) concentration. It is not known whether this genetic regulation 39 
is influenced by host characteristics. We investigated the effect of age and gender on the genetic 40 
regulation of serum 25OHD concentration. 41 
 42 
In total, 2868 Finnish men and women aged 45-74 years participated in FIN-D2D population-based 43 
health survey in 2007. Of the 2822 participants that had serum 25OHD concentration available, 2757 44 
were successfully genotyped. Age and gender-dependent association of SNPs with serum 25OHD 45 
concentration was studied in 10 SNPs with previously found association with vitamin D metabolites. 46 
 47 
Associations of 3 SNPs with serum 25OHD concentration were dependent on age with greater effects 48 
on younger (≤60 y) than older (>60y) adults (rs10783219 in VDR, rs12512631 in GC and rs3794060 49 
in NADSYN1/DHCR7; pinteraction=0.03, 0.02 and 0.01, respectively). The results suggested a novel 50 
association between serum 25OHD concentration and rs8082391 in STAT5B gene in men but not in 51 
women (pinteraction=0.01).  After multiple testing correction with false discovery rate method, two age-52 
dependent interactions (rs3794060 in NADSYN1/DHCR7 gene and rs12512631 in GC gene) remained 53 
statistically significant. 54 
 55 
This is the first study to suggest that genetic regulation of serum 25OHD concentration is age-56 
dependent. Our results also indicated a novel association between serum 25OHD concentration and 57 
SNP in STAT5B gene in men.  The results need to be confirmed in future studies preferably in a larger 58 
sample.  59 
 60 
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3 
1. INTRODUCTION  72 
 73 
Vitamin D is a prohormone that is produced in the skin through sunlight and obtained from dietary 74 
sources. The hormonally active form of vitamin D, 1,25-hydroxyvitamin D (1,25OHD), regulates 75 
calcium and phosphate absorption and bone metabolism [1]. 1,25-OHD has also important 76 
immunomodulatory properties [2]. 77 
 78 
The vitamin D status of a person is commonly estimated by measuring serum 25-hydroxyvitamin D 79 
(25OHD) concentration. 25OHD is the main vitamin D metabolite in the circulation and is the main 80 
source for the short-lived active form of vitamin D. 81 
 82 
Serum 25OHD concentration depends on the exposure to UV radiation, on the intake of vitamin D 83 
from the diet and supplements [1] as well as on physiological and life-style factors, such as age, body 84 
mass index (BMI), smoking and physical activity [3,4]. Also genetic factors affect serum 25OHD 85 
concentration. The heritability of serum 25OHD concentration has been estimated to be at least 30% 86 
[5,6] and is conferred mainly in single nucleotide polymorphisms (SNPs) in genes in the metabolic 87 
pathway of vitamin D [7-13].  88 
 89 
The metabolic pathway of vitamin D consists of several steps. Vitamin D is synthesized from 7-90 
hydrocholesterol in the skin. NADSYN1/DHCR7 locus controls the availability of 7-91 
dehydrocholesterol by converting it to cholesterol [14]. Vitamin D is converted to 25OHD mainly by 92 
CYP2R1 and to some extent by CYP27A1. In the circulation 25OHD binds to the vitamin D binding 93 
protein (DBP) (encoded by the group-specific component GC gene). Cubilin (encoded by the cubilin 94 
gene CUBN) together with megalin facilitates the renal cell uptake of the 25OHD–DBP complex. The 95 
loss of a functional cubilin results in decrease in 25OHD and 1,25OHD levels in the blood [15]. 96 
25OHD is hydroxylated to 1,25OHD by 1α-hydroxylase (encoded by CYP27B1). The active form of 97 
vitamin D acts through the intracellular transcription factor vitamin D receptor (VDR) [16].  98 
 99 
Megalin and cubilin, endocytic receptors in proximal tubule cells, are involved in the reabsorption of 100 
vitamin D binding protein from glomerular filtrates and the subsequent intracellular conversion of 25-101 
hydroxyvitamin D3 to biologically active 1α,25-dihydroxyvitamin D3. 102 
 103 
Single nucleotide polymorphisms (SNPs) associate with several diseases and with physiological traits. 104 
Some of these associations may be missed in genome-wide association studies (GWAS), since the 105 
strength of the associations can vary between different subgroups [17,18]. The most well-known 106 
factors that modify the associations of SNPs with an outcome are age and gender. For example, the 107 
associations between several SNPs and waist-to-hip-ratio, waist circumference and lipid traits have 108 
shown to be different between women and men [19-21]. Most of these associations have shown to be 109 
stronger in women than in men and have been suggested to relate with the action of sex hormones. 110 
Age has shown to modify associations between SNPs and BMI with stronger associations in younger 111 
than older adults [22-24].  112 
 113 
Our aim was to study whether age and gender affect the associations between serum 25OHD 114 




2. MATERIALS AND METHODS 119 
 120 
2.1 Study population 121 
 122 
A detailed description of the study population has been previously published [25,26]. Briefly, this 123 
study is a part of the FIN-D2D population-based health survey 2007, which is a joint project within 124 
the Finnish National Diabetes Prevention program FIN-D2D. Initially, a random sample of 4500 125 
people aged 45-74 years, stratified according to gender, 10-year age groups (45-54, 55-64, and 65-74 126 
 
4 
years), and geographical areas (Hospital Districts of Pirkanmaa, Central Finland and South 127 
Ostrobothnia), was selected from the National Population Register in August 2007. Serum samples of 128 
all participants were collected during October, November and December 2007.  129 
 130 
A total of 2868 persons (64%) participated in the health examination during October, November and 131 
December in 2007. Of these, serum 25OHD concentration was available of 2822 persons [3]. Of the 132 
2822 persons, 2785 had a DNA sample available. Genotyping failed (no result in any of the SNPs 133 
studied) in 28 samples, resulting in the final number of 2757 genotyped samples. Written informed 134 
consent was collected from all participants. The Ethics Committee of the Helsinki and Uusimaa 135 
Hospital District approved the study. 136 
 137 
2.2 Vitamin D analyses 138 
 139 
Serum 25OHD concentration measurement in this cohort has been previously described [3]. Briefly, 140 
serum 25OHD concentration was determined by chemiluminescent microparticle immunoassay by 141 
Architect i system (Abbott Laboratories, Abbott Park, IL, USA). The analytical reliability of 25OHD 142 
assay was assured by participation in the vitamin D External Quality Assessment Scheme i.e. DEQAS 143 
(Charing Cross Hospital, London UK). The bias compared to all-laboratory trimmed mean in the 144 
DEQAS was −6.4%±7.1 (mean ± SD). 145 
 146 
2.3 DNA extraction, SNP selection and genotyping 147 
 148 
Genomic DNA was extracted from whole blood using an automated Chemagen DNA extraction 149 
equipment (PerkinElmer, Waltham, MA) or using a QIAamp DNA Blood Maxi Kit (QIAGEN 150 
GmbH, Hilden, Germany) following the protocol of the kit with slight modifications. A total of 13 151 
SNPs in 7 candidate genes were initially selected on basis of evidence of associations with serum 152 
25OHD concentration in previously published studies [7-13]. SNPs in STAT5B gene, which is a 153 
member of signal transducers and activators of transcription (STATs), was selected on basis of 154 
previously found associations between 1,25OHD, VDR and STAT5 [27,28]. 155 
 156 
Genotyping was done using TaqMan (Applied Biosystems, Paisley, United Kingdom). One SNP 157 
(rs7975232) in the VDR gene was not in Hardy-Weinberg equilibrium and was excluded from further 158 
analyses. SNPs in the CYP27B1 gene (rs10877012 and rs703842) and SNPs in the STAT5B gene 159 
(rs8082391 and rs8064638) were in strong linkage disequilibrium and had identical results. Thus, the 160 
results of only one SNP of these SNP groups are presented. The final number of SNPs was therefore 161 
10.   162 
 163 
2.4 Statistical analyses 164 
 165 
Associations between SNPs and serum 25OHD concentrations were evaluated with linear regression 166 
models. The analyses were adjusted for BMI, age, smoking, vitamin D supplement use, physical 167 
activity, month of sample collection, blood glucose and triglycerides. An interaction term was 168 
included in the models to evaluate possible interaction with age / gender. Multiple testing was 169 
controlled for using the false discovery rate (FDR) method (a step-up procedure described by 170 
Benjamini and Hochberg [29], using 0.1 as the criterion). If the original p value was smaller than the 171 
Benjamini–Hochberg critical value, the interaction was considered statistically significant. Statistical 172 
analyses were carried out using Stata statistical package 12.1 (Stata-Corp. 2011, Stata Statistical 173 
Software: Release 12, College Station, TX, USA; StataCorp LP). 174 
  175 
 176 
 177 




Mean serum 25OHD concentration of the study population, as well as serum 25OHD separately for 180 
women and men, is presented in table 1. Also, serum 25OHD concentration of participants that used 181 
or did not use vitamin D containing supplements, is present in table 1.  182 
 183 
 184 








Participants that use 
vitamin D supplements 
(n) 
Participants that do not 














The association between 10 SNPs and serum 25OHD concentration in younger (≤60y) and older 190 
(>60y) adults, and in women and men, was studied in 2757 persons. 191 
 192 
Association of 3 SNPs with serum 25OHD concentration varied according to age with stronger 193 
associations in younger than older adults (rs10783219 in the VDR gene, rs12512631 in the GC gene 194 
and rs3794060 in the NADSYN1/DHCR7 gene locus; pinteraction=0.03, 0.02 and 0.01, respectively) 195 
(table 2). Age-dependent interactions in the GC gene and in the NADSYN1/DHCR7 gene locus (figure 196 




Table 2. Association of serum 25-hydroxyvitamin D concentration with SNPs in younger (≤60y; 201 
n=1425) and older (>60y; n=1332) adults.  202 
SNP Gene p Younger adults  
(≤60y) (n) 





rs731236 VDR 0.073 (1406) 0.30 (1319) 0.07  
rs4516035 VDR 0.013 (1407) 0.14 (1320) 0.27  
rs10783219 VDR 0.061 (1406) 0.075 (1320) 0.039 0.03 
rs12512631 GC 0.051 (1402) 0.18 (1316) 0.018b 0.02 
rs17470271 CYP27A1 0.59 (1402) 0.22 (1319) 0.87  
rs703842 CYP27B1 0.97 (1402) 0.49 (1320) 0.60  
rs3794060 NADSYN1
/DHCR7 
<0.001 (1407) 0.49 (1321) 0.006b 0.01 
rs8082391 STAT5B 0.88 (1407) 0.32 (1320) 0.56  
rs1801222 CUBN 0.11 (1406) 0.15 (1322) 0.31  
rs12766939 CUBN 0.59 (1406) 0.76 (1311) 0.84  
 203 
a Analyses were adjusted for BMI, smoking, vitamin D supplement use, physical activity, month of 204 
sample collection, blood glucose and triglycerides. Interaction refers to age. 205 
 
6 
bStatistically significant after multiple testing correction using false discovery rate. If the original p 206 
value was smaller than the Benjamini–Hochberg critical value, the interaction was considered 207 






Figure 1. Age-dependent association between serum 25-hydroxyvitamin D concentration and SNPs. 214 
The associations between serum 25OHD concentration and rs12512631 in GC gene and rs3794060 in 215 




One SNP (rs731236) in the VDR gene showed an age-dependent association with serum 25OHD 220 
concentration (pinteraction=0.01) before adjusted for the confounding factors (BMI, smoking, vitamin D 221 
supplement use, physical activity, month of sample collection, blood glucose and triglycerides), but 222 
this interaction did not remain statistically significant after the adjustment for these factors (p=0.07). 223 
 224 
A novel association between rs8082391in STAT5B gene with serum 25OHD concentration in men 225 
was found (p=0.008; table 3). The association was not seen in women (pinteraction=0.01; table 2). The 226 
gender-dependent interaction did not remain statistically significant after multiple testing correction 227 




Table 3. Association of serum 25OHD concentration with SNPs in women and men.  232 
 
7 
SNP Gene p Women (n) p Men (n) p (interaction)a Benjamini-
Hochberg 
critical value 
rs731236 VDR 0.67 (1423) 0.96 (1302) 0.83  
rs4516035 VDR 0.64 (1426) 0.21 (1301) 0.80  
rs10783219 VDR 0.29 (1427) 0.34 (1299) 0.17  
rs12512631 GC 0.15 (1419) 0.16 (1299) 0.47  
rs17470271 CYP27A1 0.26 (1423) 0.95 (1298) 0.70  
rs703842 CYP27B1 0.18 (1420) 0.58 (1302) 0.15  
rs3794060 NADSYN1/DHCR7 0.03 (1429) 0.006 (1299) 0.51  
rs8082391 STAT5B 0.44 (1423) 0.008 (1304) 0.01 0.01 
rs1801222 CUBN 0.24 (1426) 0.10 (1302) 0.84  
rs12766939 CUBN 1.00 (1422) 0.15 (1295) 0.39  
 233 
aAnalyses were adjusted for BMI, age, smoking, vitamin D supplement use, physical activity, month 234 




4. DISCUSSION 239 
 240 
We found that the strength of associations between serum 25OHD concentration and SNPs in the 241 
metabolic pathway of vitamin D are age-dependent with stronger associations in younger (≤60y) than 242 
older (>60y) adults. However, the present study being the first study to report this results, as well as 243 
being a small study for a genetic study, this will need to be confirmed in a larger sample.  Our results 244 
also indicate an association between serum 25OHD concentration and a SNP in STAT5B gene in men 245 
but not in women. According to our knowledge, this SNP in STAT5B gene has never been associated 246 
with serum 25OHD concentration before. In our study, the gender-dependent interaction did not, 247 
however, remain statistically significant after multiple testing correction. 248 
 249 
Strength of our study was the well-defined study population of the FIN-D2D population-based health 250 
survey 2007. We had the possibility to adjust the analyses for several vitamin D status-related 251 
physiological and life-style factors which is rarely possible in genetic studies. These factors were seen 252 
to modify results: one initially statistically significant age-dependent interaction between serum 253 
25OHD concentration and rs731236 in the VDR gene disappeared when the analyses were adjusted 254 
for vitamin D status-related factors (BMI, age, smoking, vitamin D supplement use, physical activity, 255 
month of sample collection, blood glucose and triglycerides).   256 
 257 
To our knowledge, there are no previous studies on the factors that modify the genetic component of 258 
the vitamin D status. However, several previous studies have shown that age and gender modify the 259 
associations between SNPs and an outcome, for example adiposity distribution and BMI [19-24]. In 260 
addition, it has been shown that an environmental factor can change the direction of an association 261 
between SNP and outcome: a SNP in CHRNA5-A3-B4 gene cluster has been shown to associate with 262 




Several physiological and biological changes take place when people get older, and thus age can serve 265 
as a marker of a variety of host characteristics. In our previous work of the FIN-D2D population-266 
based study we found that the mean serum 25OHD concentration is higher among older than younger 267 
adults [3]. Based on the present results, it seems that at least partly this may be explained by the fact 268 
that age affects the genetic component of the serum 25OHD concentration. 269 
 270 
The age range in our study population was limited consisting of 45 to 74-year-olds. It is possible that 271 
larger differences exist in the genetic regulation of serum 25OHD concentration for example between 272 
children and adults. This will need to be clarified in the future studies in more detail.  273 
 274 
Our results indicate a novel association between serum 25OHD concentration and rs8082391 in 275 
STAT5B gene in men. Previously it has been found that active vitamin D may exert an anti-276 
inflammatory action by influencing the crosstalk between STAT5 and the VDR [28]. VDR-STAT5 277 
complexes prevent inflammation by affecting the cytokine profile [28]. STAT5B has been shown to 278 
have a central role in the adaptive immune response and to mediate sex-dependent effects of the 279 
growth hormone [30-32]. STAT5B SNP included in the present study (rs8082391) has been suggested 280 
to affect STAT5B transcription levels [33]. The known sex-dependent effects of STAT5B gene [30] 281 
may at least partly explain the fact that in the present study the association between serum 25OHD 282 
concentrations and SNP in STAT5B gene was only seen in men.  283 
 284 
This study provides novel insight to the genetic regulation of serum 25OHD concentration. Our 285 
results suggest for the first time that there is an age-dependent effect of certain vitamin D pathway 286 
SNPs on the serum 25OHD concentration. GWAS have identified a large number of genetic variants 287 
that associate with several diseases and with physiological traits. Since these associations are 288 
influenced by environmental factors, it would be important stratify the study populations in these 289 
analyses according to relevant environmental factors and host characteristics. It is likely that in the 290 
near future plenty of new environmental, life-style and clinical factors affecting associations between 291 




This study suggests for the first time that the genetic regulation of vitamin D status through genes 296 
located in the metabolic pathway of vitamin D, is weaker among older than younger adults. The result 297 
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